Cephalexin For Suspension
NDC Package 68071-3587-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Cephalexin for suspensions is a medication used to treat a wide variety of bacterial infections. This formulation utilizes a for suspension delivery system. Marketed by Nucare Pharmaceuticals,inc., this product is identified by NDC 68071-3587 and is authorized under FDA application ANDA065234.

Identification & Billing

NDC Package Code
68071-3587-2
Package Description
200 mL in 1 BOTTLE
Product Code
68071-3587
11-Digit Billing Format
68071358702
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Cephalexin
Non-Proprietary Name
Cephalexin
Substance Name
Cephalexin
Dosage Form
For Suspension - A product, usually a solid, intended for suspension prior to administration.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
CEPHALEXIN 250 mg/5mL
Pharmacologic Class
Usage Information
This medication is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Regulatory & Marketing

Labeler Name
Nucare Pharmaceuticals,inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA065234
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-06-2017
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68071-3587-2 identifies a specific commercial package of 200 ml in 1 bottle of Cephalexin, a human prescription drug labeled by Nucare Pharmaceuticals,inc.. This for suspension is formulated for oral use and contains cephalexin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Nucare Pharmaceuticals,inc. on September 06, 2017. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

How is this Nucare Pharmaceuticals,inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68071358702. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68071-3587-2
11-Digit CMS (5-4-2)
68071-3587-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.